This study covers the world outlook for drug discovery and development RNA interference (RNAi) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the pe ...

This study covers the world outlook for RNA interference (RNAi) technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the co ...

This study covers the world outlook for antisense and RNAi therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country ...

This study covers the world outlook for RNAi therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the reg ...

This study covers the world outlook for RNAi drug deliveries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

This study covers the world outlook for RNAi therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region ...

This study covers the world outlook for RNAi technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the reg ...

The global antisense & RNAi therapeutics market size reached USD 1.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.03% during 2025-2033. The market is experiencing steady growth driven by the increasing prevale ...

Global RNA Interference (RNAi) Market to Reach US$206.7 Billion by 2030 The global market for RNA Interference (RNAi) estimated at US$116.7 Billion in the year 2024, is expected to reach US$206.7 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Drug Discovery & Dev ...

Global Antisense and RNAi Therapeutics Market to Reach US$3.6 Billion by 2030 The global market for Antisense and RNAi Therapeutics estimated at US$2.2 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA, ...

The global innovative medicine market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, the rising demand for personalized medicine, and the growing focus on research and development activities. Innovative medicines, also known as specialty dr ...

Global RNAi technology market growth is driven by growing applications of RNA interference technology in therapeutics development and research. RNA interference or RNAi refers to the process of gene silencing mediated by short interfering RNAs (siRNAs) or microRNAs (miRNAs). It has emerged as a powe ...

The 2025 Global Forecast for Mirna Tools And Services Market (2026-2031 Outlook)-High Tech Outlook Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The product or service category is within the NAICS Medical Labora ...

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a common type of amyloidosis, which affects the heart, causing heart muscles to stiffen and eventually lead to heart failure. ATTR-CM often causes symptoms of heart failure, such as fatigue, shortness of breath and peripheral edema, and other symptom ...

Antisense & RNAi Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on antisense & rnai therapeutics market which is experiencing strong grow ...

Genome Editing/Genome Engineering Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on genome editing/genome engineering market which is experiencing str ...

Market Overview The Antisense Oligonucleotides (ASOs) Market was valued at USD 2,928.00 million in 2024 and is projected to reach USD 8,063.76 million by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2032. The market is experiencing significant growth due to several key ...

The global RNA interference (RNAi) drug delivery market size reached USD 99.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 466.1 Billion by 2033, exhibiting a growth rate (CAGR) of 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to ...

Global gene editing market is projected to witness a CAGR of 17.87% during the forecast period 2025-2032, growing from USD 9.01 billion in 2024 to USD 33.57 billion in 2032. The market's growth is supported by the rising applications of gene editing in various industries, the increasing prevalence o ...

Global Viral Vectors And Plasmid DNA Manufacturing Market By Vector Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others), By Applications (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By Disease (Cancer, Genetic Disor ...

The 2025 Global Forecast for Antisense And Rnai Therapeutics Market (2026-2031 Outlook)-High Tech Outlook Report , published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 50 countries. The product or service category is within the NAICS Medic ...

The 2025 Global: Antisense And Rnai Therapeutics Market - Innovative Markets Forecast (2031) report analyzies the market size, projected growth/decline and regional data for the period 2020 through 2031. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprieta ...

Global RNA Interference (RNAi) Drug Delivery Market Growth 2024-2030 According to our LPI (LP Information) latest study, the global RNA Interference (RNAi) Drug Delivery market size was valued at US$ million in 2023. With growing demand in downstream market, the RNA Interference (RNAi) Drug Delivery ...

RNA Interference (RNAi) Pesticides Market Forecasts to 2030 – Global Analysis By Type (Synthetic RNAi Pesticides and Natural RNAi Pesticides), Mode of Action (Gene Silencing and RNA Interference), Crop Type, Application, End User and By Geography According to Stratistics MRC, the Global RNA Interfer ...

Global Antisense & RNAi Therapeutics Market Growth (Status and Outlook) 2024-2030 According to our LPI (LP Information) latest study, the global Antisense & RNAi Therapeutics market size was valued at US$ 937.7 million in 2023. With growing demand in downstream market, the Antisense & RNAi Therapeut ...